We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The first phase will evaluate whether a seven-day course of hydroxychloroquine can reduce the severity of symptoms and help avoid hospital admission. Read More
The World Health Organization (WHO) said this week that “potentially positive data” is coming out of early clinical trials of COVID-19 treatments, but it declined to name the specific drugs showing promise. Read More
Oxford University has launched a clinical trial testing existing drugs, including hydroxychloroquine and azithromycin, as preventative COVID-19 treatments in older patients. Read More
After Gilead Sciences’ remdesivir was approved for emergency use on COVID-19 patients, a number of other trials have gotten underway to test the antiviral’s benefits in combination with other drugs. Read More
The FDA yesterday updated its March guidance on managing clinical trials during COVID-19 by saying that sites can conduct patient visits via video conference with some advance planning. Read More
Sponsors of drugs to treat or prevent COVID-19 should focus on populations that are the hardest hit and least represented in clinical trials, including minorities and the elderly, according to a new FDA guidance released yesterday. Read More
The study also saw a greater portion of patients taking hydroxychloroquine with azithromycin experiencing cardiac arrest than those taking either medication alone. Read More
The Coalition for Epidemic Preparedness Innovations (CEPI) is giving Novavax an additional $384 million for development of its COVID-19 vaccine. Read More